US Platform to Measure Effectiveness of Seasonal Influenza, COVID-19 and other Respiratory Virus Vaccines for the Prevention of Acute Illness in Ambulatory Settings
Agency: Centers for Disease Control and Prevention - ERA
- 93.185 -- Immunization Research, Demonstration, Public Information and Education Training and Clinical Skills Improvement Projects
- 93.083 -- Prevention of Disease, Disability, and Death through Immunization and Control of Respiratory and Related Diseases
Archived opportunityLast Updated: May 13, 2026
View version history on Grants.gov
Description
Eligibility
Eligible applicants
Government
- Federally recognized Native American tribal governments
- County governments
- City or township governments
- Special district governments
- State governments
- Public and Indian housing authorities
Nonprofit
- Nonprofits non-higher education without 501(c)(3)
- Nonprofits non-higher education with 501(c)(3)
- Other Native American tribal organizations
Education
- Independent school districts
- Public and state institutions of higher education
- Private institutions of higher education
Miscellaneous
- Other
Business
- For-profit organizations other than small businesses
- Small businesses
Additional information
Grantor contact information
Description
AYang@cdc.gov
Documents
| File name | Description | Last updated |
|---|---|---|
| Foa_Content_of_RFA-IP-22-004.pdf | Foa_Content_of_RFA-IP-22-004.pdf | Mar 8, 2022 09:36 PM UTC |
| Foa_Content_of_RFA-IP-22-004_Amendment.pdf | Foa_Content_of_RFA-IP-22-004 Amendment.pdf | Mar 17, 2022 04:55 PM UTC |
Link to additional information
--
Archived: June 8, 2022
Award
$107,500,000
Program Funding
8
Expected awards
$2,000,000
Award Minimum
$9,100,000
Award Maximum
Funding opportunity number:
RFA-IP-22-004
Cost sharing or matching requirement:
Funding instrument type:
Cooperative agreement
Opportunity Category:
Discretionary
Opportunity Category Explanation:
Category of Funding Activity:
Health
Category Explanation:
History
Version:
3
Posted date:
March 8, 2022
Archive date:
June 8, 2022
